Thursday, May 23, 2013

Edward Myles Joins Advanced Cell Technology, Inc. (ACTC) as Chief Financial Officer

Leader in the field of regenerative medicine, Advanced Cell Technology today announced the appointment of Edward “Ted” Myles, CPA, as Chief Financial Officer and as Executive Vice President of Corporate Development. Myles will bring nearly 20 years of progressive finance and operations expertise in the life sciences industry.

Gary Rabin, chairman and CEO of ACT, stated, “Ted joins our team as we plan to list our stock on a national exchange and expand our shareholder base. Our ongoing clinical activities and pre-clinical research show promising results, and it is imperative that the operating team of the Company continue to support these exciting developments.” Rabin continues, “Ted’s experience engaging the life sciences investment community and leading corporate development and operational activities will enhance our ability to advance these programs so that we can continue to achieve clinical milestones.”

Myles commented, “ACT has made remarkable progress resolving the corporate issues that hindered the Company in the past. This provides a sound foundation from which we can build long-term relationships with institutional investors as ACT advances its promising clinical and pre-clinical programs. I look forward to working with the ACT team and with all of the Company’s stakeholders.”

Myles will be coming over from PrimeraDx, a privately held molecular diagnostics company where he sat as Chief Financial Officer and as Vice President of Operations. First joining the company in 2008, Myles helped to bring PrimeraDx to market from first conception. Prior to PrimeraDx, he served as Chief Financial Officer and Senior Vice President of life science tools company, Pressure BioSciences. While there he oversaw all compliance activities, investor relations, and oversaw many company transitions.

Earlier on in Myles career, he held financial roles with companies such as EMD Pharmaceuticals, SG Cowen Securities Corporation, Boston Biomedica, and PriceWaterhouseCoopers. Additionally he holds a master’s degree from Washington University in St. Louis in business administration with an emphasis on strategy and corporate finance. He also holds a bachelor’s degree in business administration from the University of Hartford. Myles became a Certified Public Accountant in 1996.

For more information, visit www.advancedcell.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

No comments: